COCP
Cocrystal Pharma, Inc.Company with tickers: COCP
CIK
1412486
CUSIP
19188J409
Shares Outstanding
13,787,453
13F Activity (30d)
24 filings
22 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-03 | — | |
| 8-K | 2026-05-26 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| 8-K | 2026-04-02 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-31 | — | |
| 8-K | 2026-03-13 | 2026-03-10 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-01-15 | 2026-01-09 | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-12-01 | — | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-10-30 | 2025-10-28 | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-09-15 | 2025-09-12 | |
| 8-K | 2025-09-12 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-10 | — | |
| 8-K | 2025-07-01 | 2025-06-25 | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-06-05 | — | |
| 8-K | 2025-05-29 | — | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-04-24 | — | |
| 8-K | 2025-04-23 | — | |
| 8-K | 2025-04-08 | 2025-04-02 | |
| 8-K | 2025-04-01 | 2025-03-31 | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-08 | — | |
| 8-K | 2024-12-31 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-10-10 | 2024-10-09 | |
| 8-K | 2024-08-20 | 2024-08-19 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-07-18 | — | |
| 8-K | 2024-06-28 | 2024-06-25 | |
| 8-K | 2024-06-20 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — |
Showing 1–50 of 131 filings